SEQUENT SCIENTIFIC
|
The Current P/E Ratio of SEQUENT SCIENTIFIC is 102.69.
| Share Price | ₹225.8 | May 18,2026 |
| Market Cap | ₹9,865.2 Cr | |
| Earnings-TTM | ₹96.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 102.69x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SEQUENT SCIENTIFIC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹9,865.2 Cr] as on May 18,2026
(/) Earnings [ ₹96.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 102.69x ]
Thus, for SEQUENT SCIENTIFIC , the investors are currently willing to pay 102.69 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SEQUENT SCIENTIFIC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SEQUENT SCIENTIFIC over the last five years.
Historical PE (Price/Earnings) ratio chart of SEQUENT SCIENTIFIC
PE Ratio Performance Analysis for SEQUENT SCIENTIFIC
- SEQUENT SCIENTIFIC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 58.69x.
- SEQUENT SCIENTIFIC 's operated at median p/e ratio of 62.69x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SEQUENT SCIENTIFIC 's p/e ratio peaked in Mar2025 at 149.64x.
- SEQUENT SCIENTIFIC 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does SEQUENT SCIENTIFIC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SEQUENT SCIENTIFIC | 96.07 | 102.69 | 9,865.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 41.55 | 457,121.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 73.17 | 181,396.0 |
| CIPLA LTD | 3,869.79 | 29.78 | 115,241.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 65.46 | 148,730.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 26.81 | 111,126.0 |
| MANKIND PHARMA LTD | 1,796.65 | 57.36 | 103,056.0 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 20.21 | 99,737.9 |
| LUPIN LTD | 5,355.47 | 19.23 | 103,011.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 24.59 | 86,401.6 |
| ABBOTT INDIA LTD | 1,552.02 | 38.24 | 59,344.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SEQUENT SCIENTIFIC 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.23x |
| Max industry PE | 102.69x |
| Median industry PE | 38.24x |
| Average industry PE | 45.37x |
You may also like the below Video Courses